Varian Medical Systems

Varian Medical Systems, headquartered globally in Palo Alto, California, is the world's leading manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy, and brachytherapy. The company supplies informatics software for managing comprehensive cancer clinics, radiotherapy centers and medical oncology practices. Varian is a premier supplier of tubes and digital detectors for X-ray imaging in medical, scientific, and industrial applications and also supplies X-ray imaging products for cargo screening and industrial inspection.

AbbVie

Guess?

SYNNEX

Whirlpool

While P/E gives an idea of stocks trading at a discount, PEG helps to find stocks with solid future potential.

5 Excellent GARP Picks Based on Discounted PEG

Medtronic

Stryker

Emerging market countries present lucrative prospects; consequently, investors can take a look at the space.

3 MedTech Stocks in Focus on Emerging Market Prospects

Shandong Cancer Hospital in China selects Varian (VAR) to equip its new research center with the ProBeam Proton Therapy system.

Varian's ProBeam Now Available in Multi-Room Configuration

Varian (VAR) expects the Ethos launch to boost its Oncology Systems segment.

Varian's AI-Driven Ethos Solution to Boost Global Cancer Care

Becton, Dickinson and Co.

Cerner

As cybersecurity is the need of the hour for U.S. healthcare companies, let's keep an eye on three stocks.

Cybersecurity a Top Priority for Healthcare: 3 Stocks to Watch

Varian (VAR) sees notable developments in its Proton Solutions business of late.

Varian's ProBeam Compact System Picked by University of Miami

Varian (VAR) raises the revenue guidance for fiscal 2019.

Here's Why You Should Hold Varian Medical (VAR) Stock Now

Shares slump after the radiation-therapy company reported mixed quarterly results.

Why Varian Medical Systems Is Tanking Today

Varian Medical Systems, Inc. (VAR) CEO Dow Wilson on Q3 2019 Results - Earnings Call Transcript

Probable revenue growth in APAC and EMEA regions and higher Oncology revenues are likely to aid Varian Medical (VAR) in Q3 earnings. However, contraction in margins might be a dampener.

What's in Store for Varian Medical (VAR) in Q3 Earnings?

Boston Scientific

In the wake of the U.S. tariff and Chinese retaliation, the MedTech industry players (with production houses in China) are facing huge bottom line pressure.

Will USTR's 25% Tariff Exemption Spell Relief for MedTech?

Varian (VAR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Varian Medical Systems (VAR) Earnings Expected to Grow: Should You Buy?

Abbott Labs

As India moves toward self-sufficiency, U.S. MedTech bigwigs fret over possible losses.

US-India Trade Tensions Rise: 3 Stocks in the Line of Fire

SVP, Finance & CFO of Varian Medical Systems Inc (30-Year Financial, Insider Trades) Gary E Jr Bischoping (insider trades) sold 56,232 shares of VAR on 07/11/2019 at an average price of $132.56 a share.

Varian Medical Systems Inc (VAR) SVP, Finance & CFO Gary E Jr Bischoping Sold $7..

Varian (VAR) gains from a slew of recent developments in its Proton Therapy platform.

Varian (VAR) Installs ProBeam Compact in Thailand's Hospital

Palo Alto Networks

The Trump administration will exempt 110 Chinese products, from medical equipment to key capacitors, from hefty tariffs, it said on Tuesday, offering relief to some U.S. firms which have said the taxes harm their bottom lines.

U.S. exempts some medical, electronic devices from China tariffs

Varian (VAR) expects to enhance cancer care with the new collaboration with IAEA, which is likely to drive Varian's core Oncology business.

Varian (VAR) to Boost Cancer Treatment With New Partnership

Varian (VAR) expects the buyout to prove accretive to its fiscal 2020 reported and adjusted earnings per share.

Varian to Acquire Boston Scientific's Embolic Bead Products

Varian Medical Systems (NYSE: VAR) will acquire Boston Scientific’s (NYSE: BSX) portfolio of drug-loadable microsphere and bland embolic bead products.

Varian Will Acquire Embolic Bead Asset From Boston Scientific

Varian's (VAR) core Oncology unit gets a boost from the latest collaboration with Tennessee Oncology.

Varian (VAR) & Tennessee Oncology to Implement Use of Noona

Varian Medical (VAR) expects the buyouts to prove accretive to bottom line in fiscal 2020.

Varian Medical Buys Endocare & Alicon to Boost Cancer Care

Varian's (VAR) ProBeam exhibition is in sync with its strategy to expand reach within the cancer care market.

Varian (VAR) Set to Exhibit ProBeam Proton Therapy System

Varian (VAR) reported earnings 30 days ago. What's next for the stock?

Why Is Varian (VAR) Down 4.9% Since Last Earnings Report?

Varian Medical's (VAR) APAC revenues grow 7% year over year in the fiscal second quarter.

Varian Medical Installs ProBeam at Research Hub in Singapore

Varian's (VAR) Halcyon sees encouraging developments in recent times.

News for Varian Medical Systems Stock (VAR)